Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Zhejiang Medicine Co., Ltd.
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
8,950.08 |
10,130.00 |
11,090.00 |
13,337.00 |
| Przychód Δ r/r |
0.00% |
13.18% |
9.48% |
20.26% |
| Przychód (min) |
8,341.76 |
9,843.22 |
10,546.19 |
12,815.55 |
| Przychód (max) |
9,506.72 |
10,669.39 |
12,102.39 |
14,311.23 |
| EBITDA (średnia) |
1,599.41 |
1,810.27 |
1,981.82 |
2,383.37 |
| EBIT (średnia) |
904.99 |
1,024.30 |
1,121.37 |
1,348.58 |
| EBIT % |
10.11% |
10.11% |
10.11% |
10.11% |
| Zysk netto (średni) |
1,215.52 |
1,256.42 |
1,296.29 |
1,848.00 |
| Zysk netto % |
13.58% |
12.40% |
11.69% |
13.86% |
| EPS (średnia) |
1.24 |
1.31 |
1.41 |
1.92 |
| Liczba analityków (Przychody) |
4 |
3 |
3 |
1 |
| Liczba analityków (EPS) |
3 |
1 |
3 |
1 |
| symbol |
600216.SS |
600216.SS |
600216.SS |
600216.SS |